NO20020463D0 - Nye hydantoin-, tiohydantoin-, pyrimidindion- og tioksopyrimidinonderivater, fremstillingsmetode og anvendelse sommedikamenter - Google Patents
Nye hydantoin-, tiohydantoin-, pyrimidindion- og tioksopyrimidinonderivater, fremstillingsmetode og anvendelse sommedikamenterInfo
- Publication number
- NO20020463D0 NO20020463D0 NO20020463A NO20020463A NO20020463D0 NO 20020463 D0 NO20020463 D0 NO 20020463D0 NO 20020463 A NO20020463 A NO 20020463A NO 20020463 A NO20020463 A NO 20020463A NO 20020463 D0 NO20020463 D0 NO 20020463D0
- Authority
- NO
- Norway
- Prior art keywords
- thioxopyrimidinone
- pyrimidinedione
- thiohydantoin
- drugs
- derivatives
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
- C07D233/54—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
- C07D233/66—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D233/86—Oxygen and sulfur atoms, e.g. thiohydantoin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/12—Antidiarrhoeals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/16—Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/18—Drugs for disorders of the alimentary tract or the digestive system for pancreatic disorders, e.g. pancreatic enzymes
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/02—Nasal agents, e.g. decongestants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/12—Drugs for disorders of the urinary system of the kidneys
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/06—Antipsoriatics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
- A61P19/10—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease for osteoporosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/04—Centrally acting analgesics, e.g. opioids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
- A61P29/02—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID] without antiinflammatory effect
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/04—Anorexiants; Antiobesity agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/06—Antihyperlipidemics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
- A61P35/02—Antineoplastic agents specific for leukemia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
- A61P5/02—Drugs for disorders of the endocrine system of the hypothalamic hormones, e.g. TRH, GnRH, CRH, GRH, somatostatin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
- A61P5/06—Drugs for disorders of the endocrine system of the anterior pituitary hormones, e.g. TSH, ACTH, FSH, LH, PRL, GH
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
- C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
- C07D403/04—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings directly linked by a ring-member-to-ring-member bond
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
- C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
- C07D403/06—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
- C07D403/14—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing three or more hetero rings
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
FR9909886A FR2796945B1 (fr) | 1999-07-30 | 1999-07-30 | Nouveaux derives d'hydantoines, de thiohydantoines, de pyrimidinediones et de thioxopyrimidinones, leurs procedes de preparation et leur application a titre de medicaments |
PCT/FR2000/002164 WO2001009090A2 (fr) | 1999-07-30 | 2000-07-28 | Derives d'hydantoines, de thiohydantoines, de pyrimidinediones et de thioxopyrimidinoneses, leurs procedes de preparation et leur application a titre de medicaments |
Publications (3)
Publication Number | Publication Date |
---|---|
NO20020463D0 true NO20020463D0 (no) | 2002-01-29 |
NO20020463L NO20020463L (no) | 2002-02-13 |
NO323605B1 NO323605B1 (no) | 2007-06-18 |
Family
ID=9548689
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
NO20020463A NO323605B1 (no) | 1999-07-30 | 2002-01-29 | Nye tioksotetrahydropyrimidinon- og tiohydantoinderivater, preparater av disse, fremstillingsmetode og anvendelse derav for fremstilling av medikamenter for behandling av sykdommer |
Country Status (24)
Country | Link |
---|---|
US (3) | US6759415B1 (no) |
EP (1) | EP1246807B1 (no) |
JP (1) | JP2003518011A (no) |
KR (1) | KR100712587B1 (no) |
CN (1) | CN1177828C (no) |
AR (1) | AR024939A1 (no) |
AT (1) | ATE308525T1 (no) |
AU (1) | AU779357B2 (no) |
BR (1) | BR0012852A (no) |
CA (1) | CA2380070C (no) |
CZ (1) | CZ2002301A3 (no) |
DE (1) | DE60023747T2 (no) |
DK (1) | DK1246807T3 (no) |
ES (1) | ES2252051T3 (no) |
FR (1) | FR2796945B1 (no) |
HK (1) | HK1052510B (no) |
HU (1) | HUP0202989A3 (no) |
IL (1) | IL147744A0 (no) |
MX (1) | MXPA02001016A (no) |
NO (1) | NO323605B1 (no) |
NZ (1) | NZ516718A (no) |
PL (1) | PL364726A1 (no) |
RU (1) | RU2277093C2 (no) |
WO (1) | WO2001009090A2 (no) |
Families Citing this family (22)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
GB0011071D0 (en) * | 2000-05-08 | 2000-06-28 | Novartis Ag | Organic compounds |
JP4711523B2 (ja) * | 2001-02-13 | 2011-06-29 | 日本臓器製薬株式会社 | 低アルブミン血症改善剤 |
EP1399179A4 (en) * | 2001-06-25 | 2009-07-01 | Ipsen Pharma | PHARMACEUTICAL COMPOSITIONS FOR INHIBITING PROLIFERATION OF HYPOPHYENADENOMES AND METHOD FOR THEIRIR USE |
ES2330927T3 (es) * | 2001-11-28 | 2009-12-17 | Ipsen Pharma | Derivados de 5-sulfanil-4h-1,2,4-triazoles para tratar trastornos asociados a la somatostatina. |
FR2832710B1 (fr) * | 2001-11-28 | 2004-09-03 | Sod Conseils Rech Applic | Derives de 5-sulfanyl-4h-1,2,4-triazoles et leur utilisation en tant que medicaments |
US7189856B2 (en) | 2001-12-28 | 2007-03-13 | Gideon Shapiro | Non-peptide somatostatin receptor ligands |
US7354933B2 (en) * | 2003-01-31 | 2008-04-08 | Aventis Pharma Sa | Cyclic urea derivatives, preparation thereof and pharmaceutical use thereof as kinase inhibitors |
FR2850652B1 (fr) * | 2003-01-31 | 2008-05-30 | Aventis Pharma Sa | Nouveaux derives d'uree cyclique, leur preparation et leur utilisation pharmaceutique comme inhibiteurs de kinases |
DE10325813B4 (de) * | 2003-06-06 | 2007-12-20 | Universitätsklinikum Freiburg | Prophylaxe und/oder Therapie bei der portalen Hypertonie |
EP1621539A1 (en) * | 2004-07-27 | 2006-02-01 | Aventis Pharma S.A. | Heterocycle -substituted cyclic urea derivatives, preparation thereof and pharmaceutical use thereof as kinase inhibitors |
EP1621535A1 (en) * | 2004-07-27 | 2006-02-01 | Aventis Pharma S.A. | Substituted cyclic urea derivatives, preparation thereof and pharmaceutical use thereof as kinase inhibitors |
EP1621536A1 (en) * | 2004-07-27 | 2006-02-01 | Aventis Pharma S.A. | Amino cyclic urea derivatives, preparation thereof and pharmaceutical use thereof as kinase inhibitors |
FR2896503B1 (fr) * | 2006-01-23 | 2012-07-13 | Aventis Pharma Sa | Nouveaux derives soufres d'uree cyclique, leur preparation et leur utilisation pharmaceutique comme inhibiteurs de kinases |
FR2896504B1 (fr) * | 2006-01-23 | 2012-07-13 | Aventis Pharma Sa | Nouveaux derives d'uree cyclique, leur preparation et leur utilisation pharmaceutique comme inhibiteurs de kinases |
RU2009108280A (ru) * | 2006-08-08 | 2010-09-20 | Санофи-Авентис (Fr) | Ариламиноарилалкилзамещенные имидазолидин-2,4-дионы, способы их получения, содержащие эти соединения лекарственные средства и их применение |
US8889709B2 (en) | 2006-09-21 | 2014-11-18 | Probiodrug Ag | Use of isoQC inhibitors in the treatment and prevention of inflammatory diseases or conditions |
NZ590631A (en) | 2006-09-21 | 2011-12-22 | Probiodrug Ag | Novel genes related to glutaminyl cyclase |
US9277737B2 (en) | 2006-09-21 | 2016-03-08 | Probiodrug Ag | Mouse models carrying a knock-out mutation of the QPCTL-gene |
WO2010118354A1 (en) * | 2009-04-09 | 2010-10-14 | Medivation Prostate Therapeutics, Inc. | Substituted di-arylhydantoin and di-arylthiohydantoin compounds and methods for use thereof |
UA108713C2 (xx) * | 2011-11-11 | 2015-05-25 | 2-тіопіримідинони | |
US20170281641A1 (en) * | 2014-09-03 | 2017-10-05 | Genzyme Corporation | CYCLIC UREA COMPOUNDS AS TROPOMYOSIN-RELATED KINASE (TRK) iNHIBITORS |
CN117120436A (zh) * | 2021-03-30 | 2023-11-24 | 苏州开拓药业股份有限公司 | 一种一步法合成乙内酰硫脲衍生物的方法 |
Family Cites Families (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP0912551A1 (en) * | 1996-05-14 | 1999-05-06 | Novo Nordisk A/S | Somatostatin agonists and antagonists |
ATE284694T1 (de) * | 1996-09-24 | 2005-01-15 | Taiho Pharmaceutical Co Ltd | Uracilderivate enthaltende krebsmetastasen inhibitoren |
US6025372A (en) * | 1997-04-04 | 2000-02-15 | Merck & Co., Inc. | Somatostatin agonists |
ZA985410B (en) * | 1997-06-24 | 1999-01-04 | Novo Nordisk As | Use of somatostatin agonists and antagonists for treating diseases related to the eye |
CA2335339A1 (en) | 1998-06-12 | 1999-12-16 | Societe De Conseils De Recherches Et D'applications Scientifiques (S.C.R | .beta.-carboline compounds |
DE69921124T2 (de) * | 1998-06-12 | 2005-11-10 | Société de Conseils de Recherches et d'Applications Scientifiques S.A.S. | Imidazolderivate und ihre verwendung als somatostatin rezeptorliganden |
CN1200000C (zh) | 1998-06-16 | 2005-05-04 | 研究及应用科学协会股份有限公司 | 促生长素抑制素类似物 |
-
1999
- 1999-07-30 FR FR9909886A patent/FR2796945B1/fr not_active Expired - Fee Related
-
2000
- 2000-07-25 AR ARP000103851A patent/AR024939A1/es active IP Right Grant
- 2000-07-28 CA CA2380070A patent/CA2380070C/fr not_active Expired - Fee Related
- 2000-07-28 HU HU0202989A patent/HUP0202989A3/hu unknown
- 2000-07-28 NZ NZ516718A patent/NZ516718A/xx not_active IP Right Cessation
- 2000-07-28 PL PL00364726A patent/PL364726A1/xx not_active Application Discontinuation
- 2000-07-28 AT AT00958634T patent/ATE308525T1/de not_active IP Right Cessation
- 2000-07-28 MX MXPA02001016A patent/MXPA02001016A/es active IP Right Grant
- 2000-07-28 BR BR0012852-0A patent/BR0012852A/pt not_active Application Discontinuation
- 2000-07-28 RU RU2002105024/04A patent/RU2277093C2/ru not_active IP Right Cessation
- 2000-07-28 JP JP2001514294A patent/JP2003518011A/ja active Pending
- 2000-07-28 CN CNB008110654A patent/CN1177828C/zh not_active Expired - Fee Related
- 2000-07-28 CZ CZ2002301A patent/CZ2002301A3/cs unknown
- 2000-07-28 KR KR1020027001224A patent/KR100712587B1/ko not_active IP Right Cessation
- 2000-07-28 IL IL14774400A patent/IL147744A0/xx not_active IP Right Cessation
- 2000-07-28 DK DK00958634T patent/DK1246807T3/da active
- 2000-07-28 WO PCT/FR2000/002164 patent/WO2001009090A2/fr active IP Right Grant
- 2000-07-28 ES ES00958634T patent/ES2252051T3/es not_active Expired - Lifetime
- 2000-07-28 EP EP00958634A patent/EP1246807B1/fr not_active Expired - Lifetime
- 2000-07-28 DE DE60023747T patent/DE60023747T2/de not_active Expired - Lifetime
- 2000-07-28 US US10/048,144 patent/US6759415B1/en not_active Expired - Fee Related
- 2000-07-28 AU AU70091/00A patent/AU779357B2/en not_active Ceased
-
2002
- 2002-01-29 NO NO20020463A patent/NO323605B1/no not_active IP Right Cessation
-
2003
- 2003-07-08 HK HK03104848.3A patent/HK1052510B/zh not_active IP Right Cessation
-
2004
- 2004-03-30 US US10/813,139 patent/US7199145B2/en not_active Expired - Fee Related
-
2006
- 2006-06-01 US US11/444,769 patent/US7332517B2/en not_active Expired - Fee Related
Also Published As
Similar Documents
Publication | Publication Date | Title |
---|---|---|
NO20020463D0 (no) | Nye hydantoin-, tiohydantoin-, pyrimidindion- og tioksopyrimidinonderivater, fremstillingsmetode og anvendelse sommedikamenter | |
NO20021689L (no) | 5-leddede heterocykliske derivater, fremstilling derav og anvendelse som medikamenter | |
EE200200118A (et) | Terapeutilised kinasoliini derivaadid, nende valmistamise meetod ning kasutamine | |
FR16C0042I2 (fr) | Derives de composes heterocycliques et medicaments | |
NO20024176L (no) | Farmasöytiske preparater inneholder derivater av 3-amino- azetidin, de nye derivater og deres fremstilling | |
NO20015362L (no) | Heterocyklisk substituerte benzimidazoler, deres fremstilling og anvendelse derav | |
EE05387B1 (et) | KinasoliiniÁderivaadid,ÁnendeÁvalmistamismeetodÁjaÁkasutamine | |
NO20013736D0 (no) | Pyrazolkarboksylsyrederivater, deres fremstilling og farmasöytiske preparater inneholdende de samme | |
EE200100431A (et) | 16-halogenoepotilooni derivaadid, nende valmistamismeetod ja farmatseutiline kasutamine | |
NO996433L (no) | Nye formuleringer av legemidler, fremgangsmåter for fremstilling derav og fremgangsmåter for anvendelse derav | |
NO20032726L (no) | Kinazolinderivater, medikamenter inneholdende disse forbindelser, deres anvendelse og fremgangsmåte for fremstilling derav | |
NO20012567D0 (no) | Azepinoindolderivater, fremstilling og anvendelse derav | |
PL377811A1 (pl) | Nowe cykliczne pochodne mocznika, sposób ich wytwarzania i ich zastosowanie farmaceutyczne jako inhibitorów kinazy | |
NO20013560D0 (no) | Polymorfer av telmisartan, fremgangsmåter for fremstilling derav og anvendelse derav for fremstilling av et medikament | |
NO20040268L (no) | Nye 2H-pyridazin-3-derivater, farmasoytiske preparater inneholdende slike og fremgangsmate for fremstilling av den aktive ingrediensen | |
NO20022021D0 (no) | Indeno-, nafto- og benzocyklohepta-dihydrotiazolderivater, fremstilling av de samme og deres anvendelse somanoreksilegemidler | |
EE200100422A (et) | Epotilooni derivaadid, nende valmistamismeetod jafarmatseutiline kasutamine | |
NO20032234L (no) | Nye imidazolderivater, deres fremstilling og anvendelse | |
NO20026212L (no) | Forbindelse for medikamentavleveringssystem og fremgangsmåte for fremstilling av forbindelsen | |
DK1178799T3 (da) | Gastrobeskyttede mikrogranula, fremgangsmåde til opnåelse af samme og farmaceutiske præparater | |
NO20014224L (no) | 4-heterocyklysulfonamidyl-6-metoksy-5-(2-metoksy-fenoksy)-2- pyridyl-pyrimidinderivater, fremstilling derav og anvendelse somendotelin reseptor antagonister | |
EE200100544A (et) | 15-lülilised 8a- ja 9a-laktaamid, nende valmistamismeetod ja farmatseutiline kompositsioon | |
NO20023188D0 (no) | Nye heteroarylderivater, deres fremstilling og anvendelse | |
NO20021527D0 (no) | Pyrimidinderivater, fremgangsmåte for fremstilling av derivatene og legemidler inneholdende de samme som den aktivebestanddel | |
NO20022482D0 (no) | 2-arylkinolinderivater, fremgangsmåte og terapeutisk anvendelse derav |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
MM1K | Lapsed by not paying the annual fees |